Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Ascrinvacumab by Kintor Pharmaceutical for Metastatic Hepatocellular Carcinoma (HCC): Likelihood of Approval
Ascrinvacumab is under clinical development by Kintor Pharmaceutical and currently in Phase II for Metastatic Hepatocellular Carcinoma (HCC). According to...
Data Insights
Ascrinvacumab by Kintor Pharmaceutical for Liver Cancer: Likelihood of Approval
Ascrinvacumab is under clinical development by Kintor Pharmaceutical and currently in Phase I for Liver Cancer. According to GlobalData, Phase...